Washington, DC 20006-5349
HELPLINE
On Monday, June 30 from 4:30-5:30PM Eastern Time, CancerCare is hosting a free mesothelioma teleconference workshop. The teleconference, titled Update on Mesothelioma, will feature a…
by Mary Hesdorffer, NP, Executive Director of the Meso Foundation I found myself on the treadmill looking for inspiration to go the extra mile. Two…
It was recently reported that the Mayo Clinic has successfully used the measles vaccine to eliminate cancer in a patient enrolled in an experimental trial.…
The most recent installment of the Meso Foundation’s “Meet the Mesothelioma Experts” series is now available for listening on our website. The session was held on…
Today, MolMed, an Italian pharmaceutical company, released results from its NGR-hTNF for mesothelioma clinical trial. While the trial, which enrolled 400 pleural mesothelioma patients, demonstrated…
The most recent installment of the Meso Foundation’s “Meet the Mesothelioma Experts” series is now available for listening on our website. The session was held…
It was recently reported that a clinical trial that randomized patients to receive hypnosis and cognitive therapy had a statistically significant reduction in their fatigue…
by Tao Dao, Lee M. Krug and David A. Scheinberg, Memorial Sloan Kettering Cancer Center, New York, NY Wilms’ tumor 1 (WT1) is a protein that…
The Meso Foundation would like to invite you to join us for the next installment of our Meet the Experts series: “Focused Discussion on a…
Over 40 individuals from the meso community joined us Thursday night for our latest Meet the Experts session “New Frontiers in Surgery” with Dr. Joseph Friedberg,…
